Immune inhibition of virus release from herpes simplex virus-infected cells by human sera.
Human sera contain antibody (IVR antibody) which will inhibit the release of herpes simplex virus type 1 from virus-infected cells. This antibody activity was removed by adsorption of sera with virus-infected cell extract. There was a positive correlation between IVR and neutralizing antibody activity, particularly when measured by augmented neutralization test; measurement of IVR antibody was equally as sensitive as measurement of neutralizing antibody by augmented neutralization test. IVR antibody levels provided indication of a history of recurrent herpes labialis, the pattern of antibody response following primary herpetic infection, and indication of response to Skinner herpes vaccine in human subjects. It is suggested that consideration should be given to measurement of IVR antibody in both clinical and epidemiological studies of herpes and other virus infections.
Shariff
D M
DM
Vaccine Research Foundation Ltd., Medical School, University of Birmingham, UK.
Hallworth
J
J
Desperbasques
M
M
Buchan
A
A
Skinner
G R
GR
D000914:Antibodies, Viral; D001770:Blood Bactericidal Activity; D006558:Herpes Genitalis / Q000276:immunology / Q000382:microbiology; D006560:Herpes Labialis / Q000276:immunology / Q000382:microbiology; D006801:Humans; D066298:In Vitro Techniques; D009500:Neutralization Tests; D018139:Simplexvirus / Q000276:immunology*
D000914:Antibodies, Viral